Solanezumab for Alzheimer's disease

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.6, 2011-06, pp. : 787-798

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bapineuzumab and solanezumab for Alzheimer's disease: is the `amyloid cascade hypothesis' still alive?

By Tayeb Haythum O

Expert Opinion on Biological Therapy, Vol. 13, Iss. 7, 2013-09 ,pp. : 1075-1084

Informa Healthcare

Access to resources Recommend Favorite

Gantenerumab for the treatment of Alzheimer's disease

By Delrieu Julien Ousset Pierre Jean Vellas Bruno

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 1077-1086

Informa Healthcare

Access to resources Recommend Favorite

Tau in Alzheimer's disease

By Mandelkow E.-M. Mandelkow E.

Trends in Cell Biology, Vol. 8, Iss. 11, 1998-11 ,pp. : 425-427

Elsevier

Access to resources Recommend Favorite

Role of Autophagy in Alzheimer's Disease

Current Enzyme Inhibition, Vol. 9, Iss. 1, 2013-05 ,pp. : 55-66

Bentham Science Publishers

Access to resources Recommend Favorite

Increased lipoprotein oxidation in alzheimer's disease

By Schippling S. Kontush A. Arlt S. Buhmann C. Sturenburg H.-J. Mann U. Muller-Thomsen T. Beisiegel U.

Free Radical Biology and Medicine, Vol. 28, Iss. 3, 2000-02 ,pp. : 351-360

Elsevier

Access to resources Recommend Favorite